Log in to save to my catalogue

Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth

Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5451217

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Targeted cancer therapies, which act on specific cancer-associated molecular targets, are predominantly inhibitors of oncogenic kinases. While these drugs have achieved some clinical success, the inactivation of kinase signaling via stimulation of endogenous phosphatases has received minimal attention as an alternative targeted approach. Here, we h...

Alternative Titles

Full title

Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5451217

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5451217

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI89548

How to access this item